Vasopressor Choice and Timing in Vasodilatory Shock
- PMID: 35337346
- PMCID: PMC8957156
- DOI: 10.1186/s13054-022-03911-7
Vasopressor Choice and Timing in Vasodilatory Shock
Abstract
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .
© 2022. Wieruszewski and Khanna.
Conflict of interest statement
PMW has previously received consulting fees from La Jolla Pharmaceutical Company. AKK received consulting fees and grant funding from La Jolla Pharmaceutical Company. AKK consults for Edwards Lifesciences, Medtronic, Potrero Medical, GE Healthcare, Philips North America, Caretaker Medical and Retia Medical. He is funded by an NIH/NCATS KL2 award for assessment of blood pressure and oxygenation in postoperative patients and a Wake Forest Hypertension and Vascular Research award for studying the relationship between serum renin and outcomes in patients with septic shock.
Figures


References
-
- Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–1734. - PubMed
-
- Khanna AK, Maheshwari K, Mao G, et al. Association between mean arterial pressure and acute kidney injury and a composite of myocardial injury and mortality in postoperative critically ill patients. Crit Care Med. 2019;47:910–917. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical